article thumbnail

Overlapping Ranges in Claims and Prior Art Result in Invalidation of Patent on Transdermal Patch for Parkinson’s Disease

Patently-O

In 2007, UCB invented and marketed “original Neupro,” a transdermal patch for the treatment of Parkinson’s disease containing a dispersion of amorphous rotigotine and polyvinylpyrrolidone (PVP), with the PVP functioning as a stabilizer. market in April 2008 (although it remained in limited use under a compassionate-use program).

Art 81
article thumbnail

Problem Statement Precision: A Key Factor in TSM-Based Non-Obviousness Determination?

SpicyIP

By Kevin Preji On 28th Feb, 2024, the Delhi High Court in Microsoft Technology Licensing LLC vs Assistant Controller of Patents and Designs in allowing an appeal, clarified the role of the ‘person skilled in the art’ (‘PSITA’) in determining non-obviousness. The claimed invention contained the sensor service which was absent in the prior art.

Invention 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Veuve Clicquot colour trade mark about to be cancelled?

The IPKat

The examiner of the EUIPO held that it was not an abstract colour mark but a figurative mark and refused registration for lack of distinctiveness ( Art. The trade mark was registered on 23 March 2007. 4 CTMR ) and lacked distinctiveness ( Art. The EUIPO and the BoA found that MHCS’ trade mark complied with Art.

Art 82
article thumbnail

Art. 17 DSM Directive: International Application in EU cross-border scenarios – Or: Why the EU needs a faithful implementation into national law

Kluwer Copyright Blog

Article 17 Directive (EU) 2019/790 on copyright and related rights in the Digital Single Market (“DSM Directive”) is currently being implemented into national law in the EU Member States. This has caused extensive debates on the national level comparable to the debate that took place when Art. 17 DSM Directive and Art.

Art 85
article thumbnail

Making a Proper Determination of Obviousness

Patently-O

While these new guidelines are not legally binding, they offer important insight into how the Office plans to apply an even more flexible approach to obviousness — something Director Vidal sees as mandated by the Supreme Court’s 2007 decision in KSR Int’l Co. 398 (2007). Teleflex Inc. , 2500 words). Read the Guidance Here.

Art 121
article thumbnail

Reasonable Expectation of Success as the Post-KSR Nonobviousness Hook

Patently-O

One quirk of the Patent Act is Section 271(e), which creates infringement liability for simply seeking FDA approval to market a generic version of an already approved drug. Here, Actavis filed an Abbreviated New Drug Application (ANDA) seeking FDA approval to market a “liquid methylphenidate (MPH) oral suspension.”

Art 124
article thumbnail

Delhi High Court Directs Maharaja to Pay a King’s Ransom in a Patent Infringement Suit  

SpicyIP

On the suit patent lacking novelty and obviousness, there were three prior art documents put forward. A legal notice had been issued to the defendant on September 27, 2007 and this was subsequently followed by an interim injunction on September 10, 2009. 5 Crores and divided into the two models of kettles sold by the Defendant.”.